RINVOQ |
211675 |
001 |
NDA |
UPADACITINIB |
TABLET, EXTENDED RELEASE;ORAL |
15MG |
Yes
|
No
|
2019/08/16
|
2019/08/16
|
ABBVIE |
Prescription |
RINVOQ |
211675 |
002 |
NDA |
UPADACITINIB |
TABLET, EXTENDED RELEASE;ORAL |
30MG |
Yes
|
No
|
2019/08/16
|
2022/01/14
|
ABBVIE |
Prescription |
RINVOQ |
211675 |
003 |
NDA |
UPADACITINIB |
TABLET, EXTENDED RELEASE;ORAL |
45MG |
Yes
|
Yes
|
2019/08/16
|
2022/03/16
|
ABBVIE |
Prescription |
RINVOQ LQ |
218347 |
001 |
NDA |
UPADACITINIB |
SOLUTION;ORAL |
1MG/ML |
Yes
|
Yes
|
2024/04/26
|
2024/04/26
|
ABBVIE |
Prescription |
RINVOQ |
218347 |
002 |
NDA |
UPADACITINIB |
TABLET, EXTENDED RELEASE;ORAL |
15MG |
No
|
No
|
2024/04/26
|
--
|
ABBVIE |
Prescription |
RINVOQ |
218347 |
003 |
NDA |
UPADACITINIB |
TABLET, EXTENDED RELEASE;ORAL |
30MG |
No
|
No
|
2024/04/26
|
--
|
ABBVIE |
Prescription |
RINVOQ |
218347 |
004 |
NDA |
UPADACITINIB |
TABLET, EXTENDED RELEASE;ORAL |
45MG |
No
|
No
|
2024/04/26
|
--
|
ABBVIE |
Prescription |